Results 81 to 90 of about 6,394 (171)

Association of the Monocyte–to–High-Density Lipoprotein Cholesterol Ratio With Diabetic Retinopathy

Frontiers in Cardiovascular Medicine, 2021
Background: Chronic inflammation in type 2 diabetes mellitus (T2DM) is an essential contributor to the development of diabetic retinopathy (DR). The monocyte–to–high-density lipoprotein cholesterol (HDL-C) ratio (MHR) is a novel and simple measure ...
Xixiang Tang, Xixiang Tang, Ying Tan, Yi Yang, Mei Li, Mei Li, Xuemin He, Yan Lu, Guojun Shi, Yanhua Zhu, Yuanpeng Nie, Haicheng Li, Panwei Mu, Yanming Chen   +13 more
doaj   +1 more source

To peel or not to peel the internal limiting membrane: A question finally answered? [PDF]

, 2009
Editorialpublished_or_final_versio
Wong, D
core   +1 more source

Customizing AI‐based screening with real‐world data: Practical insights from diabetic retinopathy

Acta Ophthalmologica, EarlyView.
Abstract Purpose Diabetic retinopathy (DR) is a leading cause of vision loss in middle‐aged adults globally. Although artificial intelligence (AI)‐based screening tools like IDx‐DR (classification) and Thirona RetCAD (regression) have shown high sensitivity in controlled settings, real‐world screening faces challenges due to missing or low‐quality ...
Broder Poschkamp, Liane Kantz, Petra Augstein, Allam Tayar, Lars Kaderali, Martin Busch, Beathe Bohl, Sebastian Paul, Lisa Lüdtke, Marie‐Christine Bründer, Daniel Schulz, Hanna Grabow, Elke Gens Dipl, Antonia Müller, Emily Martin, Wolfgang Kerner, Jörg Reindel, Andreas Stahl   +17 more
wiley   +1 more source

Characterising PRPF31‐associated retinal dystrophy: Clinical insights from baseline data in a natural history study

Acta Ophthalmologica, EarlyView.
Abstract Purpose To characterise the baseline clinical features and genotypes of adults with pre‐mRNA processing factor 31 (PRPF31)‐associated retinal dystrophy (RD) enrolled in a prospective, multicentre 4‐year natural history study, and to explore correlations between selected baseline parameters.
Kathrine Olaussen Eriksen, Jon Roger Eidet, Ulrika Kjellström, Jacopo Baldesi, Ragnheidur Bragadóttir, Leonardo Colombo, Josephine Prener Holtan   +6 more
wiley   +1 more source

Diabetic macular oedema and diode subthreshold micropulse laser (DIAMONDS): study protocol for a randomised controlled trial

Trials, 2019
Background In the UK, macular laser is the treatment of choice for people with diabetic macular oedema with central retinal subfield thickness (CST)
Noemi Lois, Evie Gardner, Norman Waugh, Augusto Azuara-Blanco, Hema Mistry, Danny McAuley, Nachiketa Acharya, Tariq M. Aslam, Clare Bailey, Victor Chong, Louise Downey, Haralabos Eleftheriadis, Samia Fatum, Sheena George, Faruque Ghanchi, Markus Groppe, Robin Hamilton, Geeta Menon, Ahmed Saad, Sobha Sivaprasad, Marianne Shiew, David H. Steel, James Stephen Talks, Catherine Adams, Christina Campbell, Matthew Mills, Mike Clarke, On behalf of the DIAMONDS Study Group   +27 more
doaj   +1 more source

Macular function after intravitreal triamcinolone acetonide injection for diabetic macular oedema [PDF]

Acta Ophthalmologica, 2010
Abstract.Purpose:  We aimed to evaluate the effect of intravitreal triamcinolone acetonide (IVTA) on macular function in patients with diabetic macular oedema (DMO).Methods:  Eleven eyes in 11 patients with DMO were enrolled. In each eye, at baseline and at 30 days after IVTA injection, logMAR visual acuity (VA), macular sensitivity, fixation stability
KARACORLU, Murat, OZDEMIR, Hakan, SENTURK, Fevzi, KARACORLU, Serra Arf, Uysal, Omer   +4 more
openaire   +3 more sources

Neovascular age‐related macular degeneration without drusen

Acta Ophthalmologica, EarlyView.
Abstract Purpose To describe the clinical characteristics and 1‐year follow‐up of patients with neovascular AMD (nAMD) without drusen in either eye. Methods This is a multicentre retrospective cohort study in three tertiary referral centres in The Netherlands. We included patients of 55 years or older with nAMD in one or both eyes, without the presence
Marc J. Sirks, Elon H. C. van Dijk, Husein Ghalayini, Somayeh Bazdar, WeiFeng Yu, Suzanne Yzer, José P. Martinez Ciriano, Reinier O. Schlingemann, Roselie M. H. Diederen, Camiel J. F. Boon   +9 more
wiley   +1 more source

A Comparative Study of Serum Lipid Profiles in Diabetic Patients with and without Clinically Significant Macular Oedema

TNOA Journal of Ophthalmic Science and Research
Background: Diabetes mellitus (DM) is a major health hazard today. Clinically significant macular oedema (CSME) is the most frequent cause of decreased vision in diabetic patients.
Uma Ramalingam, Radha Annamalai, Rohan Basak   +2 more
doaj   +1 more source

Inflammatory and angiogenic protein detection in the human vitreous : cytometric bead assay [PDF]

, 2011
Introduction. To evaluate clinical feasibility and reproducibility of cytometric bead assay (CBA) in nondiluted vitreous samples of patients with age-related macular degeneration (ARMD), diabetic macular edema (DME), and central retinal vein occlusion ...
Koch, Frank H., Koss, Michael Janusz, Pfister, Marcel   +2 more
core  

Intravitreal bevacizumab for the treatment of macular oedema secondary to branch retinal vein occlusion [PDF]

, 2008
Purpose: To evaluate the effect of intravitreal bevacizumab (Avastin) injections on visual acuity (VA) and foveal retinal thickness in patients with macular oedema secondary to branch retinal vein occlusion.Methods: A prospective, non-comparative ...
Alge, C. S., Burger, J., Haritoglou, Christos, Kampik, Anselm, Kook, Daniel, Kreutzer, Thomas C., Kunze, C., Priglinger, Siegfried, Strauss, R., Wolf, A. H.   +9 more
core   +1 more source